Cyclacel Pharmaceuticals (CYCC) Stock Chart & Stock Price History $0.36 +0.00 (+1.15%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Cyclacel Pharmaceuticals Stock Price Performance 5 Day Performance+1.15%1 Month Performance+13.42%3 Month Performance-74.83%6 Month Performance-78.18%Year-To-Date Performance-4.26%1 Year Performance-83.60% Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address CYCC Stock Chart for Wednesday, January, 22, 2025 CYCC Chart by TradingView Cyclacel Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/21/2025$0.36$0.36+1.15%$0.38$0.35380,055 shs$2.26 million01/20/2025$0.36$0.36$0.38$0.35245,367 shs$2.24 million01/17/2025$0.35$0.36+0.99%$0.38$0.35245,367 shs$2.24 million01/16/2025$0.37$0.35-4.76%$0.39$0.34281,838 shs$2.22 million01/15/2025$0.39$0.37-4.64%$0.38$0.36325,881 shs$2.33 million01/14/2025$0.39$0.39-0.77%$0.40$0.37389,569 shs$2.44 million01/13/2025$0.42$0.39-6.88%$0.42$0.38603,003 shs$2.46 million01/10/2025$0.41$0.42+1.21%$0.45$0.381.29 million shs$2.64 million01/09/2025$0.41$0.41$0.45$0.351.68 million shs$2.61 million01/08/2025$0.41$0.41+1.02%$0.45$0.351.68 million shs$2.61 million Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/07/2025$0.45$0.41-8.73%$0.43$0.401.38 million shs$2.58 million01/06/2025$0.46$0.45-2.17%$0.46$0.364.62 million shs$2.83 million01/03/2025$0.37$0.46+24.02%$0.89$0.43112.01 million shs$2.89 million01/02/2025$0.38$0.37-1.36%$0.39$0.37188,962 shs$2.33 million01/01/2025$0.38$0.38$0.40$0.35647,368 shs$2.36 million12/31/2024$0.37$0.38+2.73%$0.40$0.35647,368 shs$2.36 million12/30/2024$0.35$0.37+3.24%$0.39$0.321.30 million shs$2.23 million12/27/2024$0.32$0.35+9.31%$0.36$0.32352,483 shs$2.23 million12/26/2024$0.32$0.32+2.11%$0.33$0.31243,832 shs$2.04 million12/25/2024$0.32$0.32$0.33$0.31196,572 shs$2.00 million12/24/2024$0.33$0.32-2.40%$0.33$0.31196,572 shs$2.00 million12/23/2024$0.32$0.33+2.52%$0.33$0.31289,505 shs$2.05 million Related Companies Talphera Stock Chart Indaptus Therapeutics Stock Chart Conduit Pharmaceuticals Stock Chart Ensysce Biosciences Stock Chart Mainz Biomed Stock Chart SciSparc Stock Chart Biofrontera Stock Chart Cyclerion Therapeutics Stock Chart Eagle Pharmaceuticals Stock Chart Ainos Stock Chart Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCC) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYCC Stock Alerts